You are here

Clinical Trials: Cord Blood

Comment

Discuss
Body: Condition:   Inherited Metabolic Disorders (IMD)
Intervention:   Drug: Umbilical cord blood transplantation with HSC835
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting - verified March 2017
Body: Condition:   Hematologic Malignancy
Intervention:   Biological: Transplantation of cord blood expanded with UM171
Sponsors:   Maisonneuve-Rosemont Hospital;   Canadian Cancer Society Research Institute (CCSRI);   Canadian Institutes of Health Research (CIHR);   Hopital de l'Enfant-Jesus;   Vancouver General Hospital;   St. Justine's Hospital
Recruiting - verified March 2017
Body: Condition:   Lymphoma
Interventions:   Procedure: Allogeneic stem cell transplantation;   Drug: Fludarabine;   Drug: Thiotepa;   Drug: Methotrexate
Sponsors:   Massachusetts General Hospital;   Adienne SA;   Dana-Farber Cancer Institute
Withdrawn - verified March 2017
Body: Condition:   Hematologic Neoplasms
Intervention:   Procedure: Allogeneic (Allo) hematopoietic stem cell transplantation
Sponsor:   Institut Paoli-Calmettes
Recruiting - verified March 2017
Body: Condition:   Viral Infections After HSCT
Intervention:   Biological: VSTs
Sponsor:   Catherine Bollard
Recruiting - verified August 2017
Body: Condition:   Severe Hypoxic-ischemic Encephalopathy
Interventions:   Drug: HPDSC;   Drug: Cord blood
Sponsors:   New York Medical College;   Celgene
Not yet recruiting - verified May 2017
Body: Conditions:   Leukemia;   Lymphoma
Interventions:   Drug: Rituximab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Radiation;   Procedure: Fucosylated Regulatory T Cells;   Procedure: Cord Blood Infusions;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Procedure: Bone Marrow Aspiration;   Drug: G-CSF;   Procedure: Non-Fucosylated Regulatory T Cells
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI);   Targazyme, Inc.;   Cancer Prevention Research Institute of Texas
Recruiting - verified April 2017
Body: Condition:   Stroke
Intervention:   Biological: allogeneic umbilical cord blood
Sponsor:   Joanne Kurtzberg, MD
Completed - verified March 2017
Body: Conditions:   Sickle Cell Disease;   Thalassemia
Intervention:   Biological: CordIn
Sponsor:   Gamida Cell ltd
Recruiting - verified September 2016
Body: Condition:   Metabolic Disorders
Intervention:   Biological: ProHema-CB Transplant
Sponsor:   Fate Therapeutics
Terminated - verified October 2015
Body: Condition:   Leukemia, Myeloid
Interventions:   Drug: IV Thiotepa;   Drug: IV Fludarabine;   Drug: IV Busulfan;   Drug: IV Anti-thymocyte globuline
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting
Body: Condition:   Acute Myeloid Leukemia
Interventions:   Drug: chemotherapy (Mitoxantrone, Cytarabine);   Drug: Placebo;   Drug: Crenolanib;   Other: Allogeneic stem cell transplantation
Sponsor:   University of Ulm
Recruiting - verified March 2017
Body: Condition:   Mesenchymal Stromal Cells
Intervention:   Drug: pneumostem
Sponsor:   Samsung Medical Center
Completed - verified April 2017
Body: Conditions:   Primary Myelofibrosis;   Secondary Myelofibrosis
Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan;   Drug: Methotrexate;   Drug: Momelotinib;   Drug: Mycophenolate Mofetil;   Drug: Pacritinib;   Drug: Ruxolitinib;   Drug: Tacrolimus;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2017
Body: Condition:   Hematological Malignancies
Interventions:   Drug: Cyclophosphamide;   Drug: Thiotepa;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Mesna;   Biological: G-CSF;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Drug: Methylprednisolone;   Radiation: Total lymphoid irradiation;   Biological: Lymphocyte infusions;   Device: CliniMACS
Sponsor:   St. Jude Children's Research Hospital
Recruiting - verified August 2016

Pages